Unlock Your Specialty Pharmacy’s Hidden Value [INFOGRAPHIC]https://shieldshealthsolutions.com/content/uploads/2026/01/Blog-icon-for-social-200x200-1.png200200Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
See how your health system can retain specialty volume, strengthen financial performance, and improve patient outcomes with the right strategy and support. Health systems without fully integrated specialty pharmacy models…
Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happeninghttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2025 marked its 21st anniversary — and we couldn’t be…
Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacieshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.
Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medicationshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.
Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditationhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.
Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancerhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the clinical and quality outcomes of a bleeding disorder program in a health system specialty pharmacy.
The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivityhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.
Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Programhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.
Clinical Outcomes Evaluation of a Pharmacist Led Social Determinants of Health Screening and Intervention Pilothttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the impact on clinical outcomes of a pharmacist-led social determinants of health (SDOH) screening and intervention program within the rheumatoid arthritis population of a health system specialty…